Process for the preparation of 2-amino-2- [2- (4-C3-C21-alkyl-phenyl)ethyl] propane-1, 3-diols

Details for Australian Patent Application No. 2009226975 (hide)

Owner Novartis AG

Inventors Sedelmeier, Gottfried

Agent Davies Collison Cave

Pub. Number AU-B-2009226975

PCT Pub. Number WO2009/115534

Priority 08153033.9 19.03.08 EP

Filing date 17 March 2009

Wipo publication date 24 September 2009

Acceptance publication date 6 September 2012

International Classifications

C07C 213/08 Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton

A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 37/06 Drugs for immunological or allergic disorders

C07C 215/28 Compounds containing amino and hydroxy groups bound to the same carbon skeleton

C07C 233/18 Carboxylic acid amides

C07C 233/47 Carboxylic acid amides

Event Publications

7 October 2010 PCT application entered the National Phase

  PCT publication WO2009/115534 Priority application(s): WO2009/115534

6 September 2012 Application Accepted

  Published as AU-B-2009226975

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009226988-Trisubstituted 1, 2, 4 -triazoles as nicotinic acetylcholine receptor modulators

2009226972-YopM as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions